ライフサイエンスコーパス: carcinoma cell line

1 in the HN5 human head and neck squamous cell carcinoma cell line.

2 unit of calpain 2 in the AC2M2 mouse mammary carcinoma cell line.

3 leukemia cell lines and one human colorectal carcinoma cell line.

4 nating variants from the human PC-3 prostate carcinoma cell line.

5 ptotic responses in the NRP-154 rat prostate carcinoma cell line.

6 ere tested for protein production in a human carcinoma cell line.

7 ies against the Met dependent GTL-16 gastric carcinoma cell line.

8 -A (JAM-A) in the HepG2 human hepatocellular carcinoma cell line.

9 terally by the CT26 wild type (CT26WT) colon carcinoma cell line.

10 five normal human tissues, and an embryonal carcinoma cell line.

11 sis induction in the BxPC-3 human pancreatic carcinoma cell line.

12 cytotoxicity against Colo-205, a human colon carcinoma cell line.

13 s and MixMHCpred on new data from an ovarian carcinoma cell line.

14 multiple nude mice xenografted with the A431 carcinoma cell line.

15 channel (KATP) in HepG2C3A, a hepatocellular carcinoma cell line.

16 ed in vitro using the HCT116/LUC human colon carcinoma cell line.

17 n of Merkel cell polyomavirus(+) Merkel cell carcinoma cell lines.

18 for viral E6 expression in infected cervical carcinoma cell lines.

19 and O-GlcNAc levels are elevated in prostate carcinoma cell lines.

20 cell sorting analysis in a variety of human carcinoma cell lines.

21 autophagic phenotype in HeLa and other human carcinoma cell lines.

22 Mahlavu liver, MCF7 breast, and HCT116 colon carcinoma cell lines.

23 liferative effects on a panel hepatocellular carcinoma cell lines.

24 ed down-regulation of FOSL1 in squamous cell carcinoma cell lines.

25 ain human prostate epithelial carcinomas and carcinoma cell lines.

26 endocrine sensitive but not resistant breast carcinoma cell lines.

27 ) and fulvestrant (ICI182780; ICI) in breast carcinoma cell lines.

28 ced motility and invasiveness of other colon carcinoma cell lines.

29 ling activation in a series of human gastric carcinoma cell lines.

30 hed the clonogenicity of all six human colon carcinoma cell lines.

31 ndent on JMJD1A in both renal cell and colon carcinoma cell lines.

32 ted depletion of HAX-1 in oral squamous cell carcinoma cell lines.

33 u and Cal27, two head and neck squamous cell carcinoma cell lines.

34 line but selective activities against human carcinoma cell lines.

35 tic melanoma, prostate carcinoma, or mammary carcinoma cell lines.

36 1 in HaCaT cells or in several squamous cell carcinoma cell lines.

37 against LNCaP, DU145, and PC3 human prostate carcinoma cell lines.

38 ocytes and human oropharyngeal squamous cell carcinoma cell lines.

39 odiol in the cell cycle progression of human carcinoma cell lines.

40 capacity of MDA-MB-231 and MDA-MB-435 breast carcinoma cell lines.

41 SPR-Cas9 technology impacted the adhesion of carcinoma cell lines.

42 lphaB-crystallin in two different metastatic carcinoma cell lines.

43 ion in both papillary and follicular thyroid carcinoma cell lines.

44 cell lines, including human liver and rectal carcinoma cell lines.

45 ion of HeLa cells compared to hepatocellular carcinoma cell lines.

46 ar, salivary gland, cervical, and pancreatic carcinoma cell lines.

47 ty and cell uptake data in two human ovarian carcinoma cell lines.

48 icity of meayamycin B in non-small cell lung carcinoma cell lines.

49 sses metastasis in multiple human and murine carcinoma cell lines.

50 sion and metastatic growth of hepatocellular carcinoma cell lines.

51 report, we characterized the human prostate carcinoma cell line 22Rv1 in an orthotopic system and ev

52 on tumor behavior, using the murine mammary carcinoma cell line 4T1.

53 vical carcinoma cell line HeLa and the renal carcinoma cell line 786-O.

54 rapy of 2 alphavbeta3-negative squamous cell carcinoma cell lines (A-431 and FaDu) that induce alphav

55 n present in human genomic DNA from a ductal carcinoma cell line, a mutation commonly found in breast

56 nce in intrinsic HH dependence of urothelial carcinoma cell lines, a gene expression signature was id

57 ty assay in human fibroblasts (MRC5) and two carcinoma cell lines (A375 and HCT116), interaction with

58 rathyroid glands and in the human epidermoid carcinoma cell line A431, which mimics hyperplastic para

59 ta from perturbation experiments in squamous carcinoma cell line A431.

60 C3G inhibited proliferation of a human lung carcinoma cell line, A549.

61 l cells (including the C666-1 nasopharyngeal carcinoma cell line), although Na does not appear to aff

62 ISPR-Cas9-mediated screen using a human lung carcinoma cell line and identify semaphorin (SEMA) 6A an

63 azole 1 in growth inhibition of HCT116 colon carcinoma cell line and in inducing increases in global

64 t in vitro uptake within the DU-145 prostate carcinoma cell line and orthotopically implanted prostat

65 ed subcutaneously with a non-small cell lung carcinoma cell line and treated with paclitaxel for a pr

66 rom a 40-gene signature and is found in both carcinoma cell lines and a variety of primary tumors, in

67 the loss of EphB6 protein in invasive breast carcinoma cell lines and absence of EphB6 transcript in

68 on-small-cell lung cancer and hepatocellular carcinoma cell lines and also hepatocellular carcinoma,

69 expression was elevated in half of the human carcinoma cell lines and carcinoma tissue samples tested

70 cells from early stage human lung and breast carcinoma cell lines and defined the mechanisms that sup

71 er small RNA segments for six human cervical carcinoma cell lines and five normal cervical samples.

72 ession were examined in human hepatocellular carcinoma cell lines and human liver tissue.

73 ion were immunoprecipitated from human colon carcinoma cell lines and identified by mass spectrometry

74 In 11 of 13 (85%) renal cell carcinoma cell lines and in 16 of 37 (43%) other cancer

75 ownstream target genes and proteins in renal carcinoma cell lines and in a mouse xenograft model of r

76 mediated autophagy in Her2-expressing breast carcinoma cell lines and in Beclin-1 signaling in these

77 is a potent inducer of invadopodia, both in carcinoma cell lines and in primary human fibroblasts.

78 llels reduced EPHB3 expression in colorectal carcinoma cell lines and poorly differentiated tumor-tis

79 epithelial and mesenchymal clones from human carcinoma cell lines and showed that the epithelial clon

80 urine liver and human HCC, breast, and colon carcinoma cell lines and specimens.

81 ated-EGFR (p-EGFR) and miR-21 levels in lung carcinoma cell lines and the suppression of miR-21 by an

82 FGFR1 expression is increased in urothelial carcinoma cell lines and tumors, which promotes prolifer

83 splice variants of FGFR1 in both urothelial carcinoma cell lines and tumors.

84 esent in several head and neck squamous cell carcinoma cell lines and was required for processing and

85 eat/beta-galactosidase cells (human cervical carcinoma cell line) and CEMx174 cells (human T cell lin

86 .e., HepG2 cells (human hepatocellular liver carcinoma cell line) and HL-7701 cells (human normal liv

87 ion of KYSE-410, an esophageal squamous cell carcinoma cell line, and fibroblasts with respect to the

88 SCC-25 cells, a human squamous cell carcinoma cell line, and primary keratinocytes were eith

89 uman breast tumor cohorts, a panel of breast carcinoma cell lines, and hepatocellular carcinomas from

90 analysis of a human pituitary tumor, breast carcinoma cell lines, and thyroid carcinoma cell lines s

91 ed normal human urothelial cells, urothelial carcinoma cell lines, and tumor samples and showed that

92 anges mediated by VEGFR-1 in this pancreatic carcinoma cell line are highly consistent with the chang

93 ent adenovirus, Ad.mda-7, several colorectal carcinoma cell lines are resistant to its antiproliferat

94 nflammation in many primary human tumors and carcinoma cell lines as distinct from their normal tissu

95 ant form of PAX6, is expressed in pancreatic carcinoma cell lines at higher levels than the canonical

96 alization to the nucleus of human colorectal carcinoma cell lines at low cell culture densities and h

97 cals profiled in HepG2 (human hepatocellular carcinoma cell line) at multiple doses and replicates.

98 tion of FGFR2 kinase activity in endometrial carcinoma cell lines bearing such FGFR2 mutations inhibi

99 variety of breast cancer and hepatocellular carcinoma cell lines, but not to normal-like MCF-10a bre

100 expression in H358 human non-small cell lung carcinoma cell line by blocking CDK2 activity.

101 Utilizing prostate carcinoma cell lines (C1, C2, and C3) derived from TRAMP

102 tive effects were evaluated in human colonic carcinoma cell line Caco-2 and neonatal rat models.

103 n cancer cell line A2780, the human squamous carcinoma cell line Cal27, and their cisplatin resistant

104 ancer cell line A2780 and the human squamous carcinoma cell line Cal27.

105 melanoma cell line SK-MEL-37, and pancreatic carcinoma cell line Capan-1 by the same mechanism.

106 inhibition of SIM2-s in a RKO-derived colon carcinoma cell line causes growth inhibition, apoptosis,

107 we report the generation of a choroid plexus carcinoma cell line; Children's Cancer Hospital Egypt (C

108 We show here in both pancreatic and prostate carcinoma cell lines cobalt chloride (used to mimic hypo

109 Knockdown of EBP50 in human colorectal carcinoma cell lines compromised cell cycle progression,

110 ates a subset of p53 target genes in a colon carcinoma cell line, consistent with the observation tha

111 Nasopharyngeal carcinoma cell lines constitutively expressed C/EBPbeta

112 bicin on chromatin dynamics in squamous cell carcinoma cell lines derived from genetically defined mi

113 pVHL-defective clear cell renal cell carcinoma cell lines display unexpectedly variable sensi

114 lls have functional Sdccag1, five human lung carcinoma cell lines do not, even though Exportin still

115 r metastasis, we used two different prostate carcinoma cell lines, DU145 and PC3, in which the expres

116 In several male carcinoma cell lines, DXZ4 can adopt a Xi-like conformat

117 ecific antitumor agent against MCF-7 (breast carcinoma) cell lines (ED50 = 3.7 x 10(-3) microg/mL com

118 ) expression) or the BxPC-3 human pancreatic carcinoma cell line (endogenous alpha(v)beta(6) expressi

119 d human urothelial cells and many urothelial carcinoma cell lines exhibit constitutive HH signaling,

120 We find that ovarian carcinoma cell lines exhibit greater sensitivity to apop

121 However, four of five pancreatic carcinoma cell lines exhibited either elevated Mirk acti

122 ntrast, tumors arising from more mesenchymal carcinoma cell lines exhibiting EMT markers expressed lo

123 imary human hepatocytes and 4 hepatocellular carcinoma cell lines exposed to combinations of cytokine

124 ary tumor cells arising from more epithelial carcinoma cell lines expressed high levels of MHC-I, low

125 In contrast, the human C2Bbe1 colorectal carcinoma cell line expresses little caspase-1 but inste

126 recently demonstrated that the LS174T colon carcinoma cell line expresses the CD44 glycoform known a

127 ted cell growth of an aggressive human colon carcinoma cell line, FET6alphaS26X, which harbors consti

128 approach to knockdown CYP1B1 in endometrial carcinoma cell line followed by functional assays.

129 Thus, six of seven colon carcinoma cell lines from the NCI Anticancer Drug Screen

130 (+) pump) has been studied in the human lung carcinoma cell line H1299 that expresses YFP-tagged alph

131 ability, and cellular ATP levels of the lung carcinoma cell lines H1299 and A549.

132 A human adrenal carcinoma cell line (H295R) overexpressing human aldoste

133 onged exposure of a gefitinib-sensitive lung carcinoma cell line (H3255; EGFR mutated and amplified)

134 ed the migratory behavior of a squamous cell carcinoma cell line (HaCaT-II-4) upon E-cadherin suppres

135 We found a colorectal carcinoma cell line harboring the fusion gene to be depe

136 neddylation of Cul1 and Cul3 in two squamous carcinoma cell lines harboring DCN1 amplification.

137 lNapOH- and XylNap-primed GAGs from a breast carcinoma cell line, HCC70, and a breast fibroblast cell

138 identified LSR splice variants in the colon carcinoma cell line HCT116 and disrupted the LSR gene in

139 1 conditional allele in the human colorectal carcinoma cell line HCT116 in which several exons encodi

140 ucture-dependent toxicity to the human colon carcinoma cell-line HCT116 p53(++), causing dramatic cha

141 ays controlled by p53, isogeneic human colon carcinoma cell lines (HCT116) differing only in the pres

142 tive activities against the human colorectal carcinoma cell lines HCT116N and HCT116O, an isogenic mo

143 ts between two unrelated cells, the cervical carcinoma cell line HeLa and the renal carcinoma cell li

144 e, we show that pretreatment of two cervical carcinoma cell lines, HeLa and SiHa, with curcumin befor

145 ss miR-515 and are HER2-, the hepatocellular carcinoma cell line HepG2 and the TNBC line MDA-MB-231.

146 (50) 3.2 ng mL(-1)) against the human hepato-carcinoma cell line HepG2 over both the human leukemia c

147 colon cancer cell line HT-29, hepatocellular carcinoma cell line HepG2, melanoma cell line SK-MEL-37,

148 nous expression levels in the hepatocellular carcinoma cell line HepG2.

149 studied using the human liver hepatocellular carcinoma cell line HepG2.

150 odels consisting of the human hepatocellular carcinoma cell line (HepG2) and primary rat hepatocytes

151 induced effects using a human hepatocellular carcinoma cell line, HepG2 cells.

152 nce, restoration of expression in a prostate carcinoma cell line homozygous for the frameshift mutati

153 3611 rendered the strain cytotoxic to a lung carcinoma cell line; however, only prtS induction was su

154 ival fibroblasts and the oral human squamous carcinoma cell line HSC-2 were exposed to interleukin (I

155 cell line, HaCaT, but did in a human gastric carcinoma cell line, HSC-39.

156 ell cytotoxicity assays with the human colon carcinoma cell line (HT-29) showed that internalized NCP

157 apoptosis and cell cycle in the human colon carcinoma cell line, HT-29.

158 Adenoma (PC/AA/C1 and RG/C2) and carcinoma cell lines (HT29) were growth stimulated by PG

159 usion protein (114 kD) in the hepatocellular carcinoma cell line HUH7, as well as in liver tumors, es

160 regulation of MIR122 in human hepatocellular carcinoma cell lines (Huh7 and HepG2) as well as in C57B

161 modifications in five ovarian epithelial and carcinoma cell lines (human 'immortalized' ovarian surfa

162 a study of gene expression in the RKO colon carcinoma cell line in response to varying dosage levels

163 growth of human head and neck squamous cell carcinoma cell lines in 3D cell culture and in xenograft

164 various mouse tumor models employing murine carcinoma cell lines in immunocompetent mice.

165 cessfully characterized SCLCCs from 2 murine carcinoma cell lines in the immune-competent microenviro

166 or activity against colon, renal, and breast carcinoma cell lines in vitro (GI50 < 500 nmol/L).

167 tant and metastatic phenotype in human colon carcinoma cell lines in vitro.

168 s migration of Burkitt's lymphoma and breast carcinoma cell lines in vitro.

169 totoxic to PA-1, IGROV-1, and SK-OV3 ovarian carcinoma cell lines in vitro.

170 into A549 cells, a highly transducible lung carcinoma cell line, in comparison to well-studied simia

171 Overexpression of HER2 in a series of breast carcinoma cell lines increases the ALDH-expressing 'canc

172 anscript inhibited the migration of multiple carcinoma cell lines, indicating a broad role in cell mo

173 Overexpression of KLF4 in a human pancreatic carcinoma cell line induced a significant decrease in th

174 iated TRPC1 depletion in non small cell lung carcinoma cell lines induced G(0)/G(1) cell cycle arrest

175 In the human HT29Cl16E colonic carcinoma cell line, induction of goblet cell differenti

176 cells (SCLCCs) from the 4T1 and NXS2 murine carcinoma cell lines into the immune-competent microenvi

177 dogenous c-KIT expression in a human gastric carcinoma cell line is also reduced on treatment with th

178 We show that the D121 lung carcinoma cell line is E(2)-nonresponsive, and following

179 ession in choriocarcinoma, hepatoma and lung carcinoma cell lines is driven by the activity of a 66 b

180 ssed EGFRs in A431 cells, a human epidermoid carcinoma cell line, is composed of two subpopulations t

181 nsitive detection of HepG2, a hepatocellular carcinoma cell line, is described.

182 endometrial tissue and that the endometrial carcinoma cell line, Ishikawa, contains the receptors to

183 he cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resistant s

184 ostic properties against the human epidermal carcinoma cell line KB3-1.

185 , and blot rolling assays of LS174T, a colon carcinoma cell line known to interact with E-selectin un

186 of activity in the resistant A2780AD ovarian carcinoma cell line known to overexpress the ABCB1 drug

187 OXE1 and PTCSC2 in a human papillary thyroid carcinoma cell line (KTC-1) and unaffected thyroid tissu

188 In aggressive prostate and breast carcinoma cell lines, laminin-binding glycans are dramat

189 nduction of apoptosis in the human prostatic carcinoma cell line LNCaP.

190 his cyclase was investigated in the prostate carcinoma cell lines LNCaP and PC3.

191 The ovarian carcinoma cell line MA148 was genetically modified by "S

192 ignaling via the HER2/HER3 pathway in breast carcinoma cell lines may lead to enhanced NKG2D-MICA/B r

193 YAMC cells, the mouse colon carcinoma cell line MC38, the mouse macrophage cell line

194 genicity, and metastasis in Smad4-null colon carcinoma cell lines (MC38 and SW620) and in those that

195 Es), repressing transcription in the mammary carcinoma cell line MCF-7.

196 cytotoxic activity of (+)-T7 against breast carcinoma cell line MCF-7.

197 of caspase 9 gene expression in the mammary carcinoma cell line MCF-7.

198 strogen receptor-positive (ER+) human breast carcinoma cell line, MCF-7, and examined the effect of e

199 for gelatin matrix degradation in the breast carcinoma cell line MDA-MB-231.

200 Metastatic human breast carcinoma cell lines MDA-MB-231 and -435 expressing enha

201 t cell line, MCF10A, and the invasive breast carcinoma cell line, MDA-MB-231.

202 highly metastatic and invasive human breast carcinoma cell line, MDA-MB231.

203 tromal cells (MSCs) and two different breast carcinoma cell lines, MDA-MB-231 (MDA) and MA11.

204 el mouse hepatocellular SV40 large T-antigen carcinoma cell line, MHT that maintains the ability to e

205 l suspension of SCC7, a murine squamous cell carcinoma cell line; mice (n = 32) in drug delivery stud

206 we generated three isogenic human colorectal carcinoma cell line models in which we can dynamically m

207 Treatment of the human metastatic breast carcinoma cell line MT-2 with MDL28170 and 3-(4-iodophen

208 The lung carcinoma cell line NCI-H522 was found to express JAM-C.

209 nd Bcl-XL proteins and a non-small-cell lung carcinoma cell line (NCI-H460).

210 yed two EMT cell models, the human embryonic carcinoma cell line NT2/D1, and TGF-beta1-treated NMuMG

211 In the embryonal carcinoma cell line NT2/D1, ectopic DeltaN-p63-alpha dis

212 l regulator Six1 is overexpressed in ovarian carcinoma cell lines (OCC) compared with normal ovarian

213 expressed on the cell surface of peritoneal carcinoma cell lines of gastric (MKN-45P), ovarian (SKOV

214 eport MRN deficiency in three of seven colon carcinoma cell lines of the NCI Anticancer Drug Screen.

215 st breast, lung, cervical and hepatocellular carcinoma cell lines) of their methanolic extract, infus

216 n the presence of primary oral squamous cell carcinoma cell lines or coincubated with purified gangli

217 ls resulting from the culture of human colon carcinoma cell lines or primary mouse epithelial cells l

218 ancer stem cell markers in the human ovarian carcinoma cell line, OVCAR-5, and is also highly express

219 ocus in retinoic acid (RA)-treated embryonal carcinoma cell line P19, which involves receptor-interac

220 ng neuronal differentiation of the embryonic carcinoma cell line P19.

221 The exocrine human pancreas carcinoma cell line (PANC-1) and the endocrine human ins

222 ntial display analysis of the human prostate carcinoma cell line PC-3 and its highly metastatic deriv

223 wth factor (VEGF) in vitro in human prostate carcinoma cell line PC-3.

224 p72 did not reduce viability of the prostate carcinoma cell lines PC-3 and DU-145.

225 ved HSP70 release from intact human prostate carcinoma cell lines (PC-3 and LNCaP) by a mechanism ind

226 A cisplatin-resistant ovarian carcinoma cell line PE01CDDP was derived from the parent

227 rporated into cells from the human prostatic carcinoma cell line PPC-1, and shows no apparent cytotox

228 bound to the NRP-positive primary prostatic carcinoma cell line (PPC-1) but did not bind to the NRP-

229 expression is suppressed in hypermethylated carcinoma cell lines (R=-0.73).

230 tive to benign ovarian tumors and in ovarian carcinoma cell lines relative to immortalized surface ep

231 s were cocultured with the murine renal cell carcinoma cell line, Renca, a dramatic increase in apopt

232 epithelial cells, and in breast and ovarian carcinoma cell lines, represses IFN-stimulated genes (IS

233 kdown in UM-UC-3 and TCCSUP human urothelial carcinoma cell lines resulted in suppression of CD24 exp

234 7A inhibited LOX activity in the 4T1 mammary carcinoma cell line, resulting in a loss of LOX-dependen

235 Depletion of REGgamma in a thyroid carcinoma cell line results in cell-cycle and proliferat

236 RT-PCR analysis in carcinoma cell lines revealed a significant reduction in

237 Knockdown of FGFR1 in urothelial carcinoma cell lines revealed differential FGFR1 depende

238 also likely to be present in a human tongue carcinoma cell line, SAS.

239 icity for the protected compounds in ovarian carcinoma cell lines sensitive and resistant to cisplati

240 ur expression in head and neck squamous cell carcinoma cell lines showed a mechanistic link between f

241 or, breast carcinoma cell lines, and thyroid carcinoma cell lines showed that in cells expressing Gal

242 We observed that the hepatocellular carcinoma cell line SKHEP1 retains productive free uptak

243 ock the migration of a highly motile ovarian carcinoma cell line, SKOV-3, by using a 384-well wound-h

244 The human renal cell carcinoma cell line SN12-C was stably transfected with p

245 We utilized the highly sensitive gastric carcinoma cell line, SNU638, and two related MET inhibit

246 t MHC class I tumor antigen of a mouse colon carcinoma cell line stimulates a tumor-specific T-cell c

247 pha-positive but not ERalpha-negative breast carcinoma cell lines, suggesting that ERbeta1 represses

248 showed in a BRG1- and BRM1-deficient adrenal carcinoma cell line, SW-13, that Tax- and 21-bp repeat-m

249 ylation profiles of the isogenic human colon carcinoma cell lines SW480 (primary tumor) and SW620 (me

250 of EGFR immune complexes from a transitional carcinoma cell line (TCCSUP) identified the phosphoinosi

251 ein expression was reduced in 6 of 16 breast carcinoma cell lines tested as compared with untransform

252 Most human ovarian carcinoma cell lines tested secreted significant levels

253 In several human carcinoma cell lines tested, HeLa (cervical), HCT116 and

254 than Ad5 WT, dl309, or dl1520 in all ovarian carcinoma cell lines tested, which was associated with e

255 on was 2.3-fold higher in G/G hepatocellular carcinoma cell lines than A/A cell lines.

256 ithelial cell line and in a low-grade serous carcinoma cell line that expressed undetectable levels o

257 beta4 in tumor progression, a SUM-159 breast carcinoma cell line that is essentially devoid of alpha6

258 BT549 is an invasive human breast carcinoma cell line that lacks expression of BAF57, a ke

259 or lactate uptake by a human cervix squamous carcinoma cell line that preferentially utilized lactate

260 ression, we generated novel isogenic colonic carcinoma cell lines that exhibit highly significant, st

261 as used to block HH signaling in human colon carcinoma cell lines that express HH signaling component

262 We established RKO (human colorectal carcinoma) cell lines that can be induced by doxycycline

263 In a series of carcinoma cell lines, the IC50 for proliferation ranged

264 ERalpha-transfected ERalpha-negative breast carcinoma cell lines, the MDA-MB-468 and the MDA-MB-231

265 kappaB activation in five of six human colon carcinoma cell lines; this activation is inhibited by qu

266 iated ROS generation in the HT29 human colon carcinoma cell line through a Rac-dependent mechanism.

267 to a site 100 kb from a telomere in a human carcinoma cell line to address the effect of telomere pr

268 stablished model based on control of a mouse carcinoma cell line to study endogenous tumor-infiltrati

269 ferentiated and differentiated human colonic carcinoma cell lines to determine if this parasite speci

270 tes Chk1, also sensitized a variety of human carcinoma cell lines to SN-38.

271 roup, we used a preclinical model of bladder carcinoma cell lines to study a unique SV (translocation

272 Overexpression of IHPK2 sensitized ovarian carcinoma cell lines to the growth-suppressive and apopt

273 the responses of head and neck squamous cell carcinoma cell lines to two IFN subtypes, IFN-alpha2a an

274 ur potential selective to colon and cervical carcinoma cell lines) to be explored in the pharmaceutic

275 ed hemaglutinin-tagged GALR1 in a human oral carcinoma cell line (UM-SCC-1-GALR1) that expresses no e

276 roperties in two head and neck squamous cell carcinoma cell lines, UMSCC-10B and HN-1.

277 Three human head and neck squamous carcinoma cell lines (UMSCC1, UMSCC14A, and UMSCC22A) we

278 was measured in HCT-116, a human colorectal carcinoma cell line, using inhibitors of SHP2 and RAF.

279 ted with the 256 variants in the NCI-60 lung carcinoma cell lines, valine with high expression and is

280 e promoter methylation status of three renal carcinoma cell lines was assessed with restriction enzym

281 pression in several EBV-infected AGS gastric carcinoma cell lines was determined.

282 stitutive HH activity observed in urothelial carcinoma cell lines was HH ligand dependent.

283 inatorial mutations in the human ES2 ovarian carcinoma cell line were also assessed with TRACE.

284 ) and anaplastic (CAL62 and FRO82-1) thyroid carcinoma cell lines were characterized via Western blot

285 Mouse serous and endometrioid ovarian carcinoma cell lines were tested in vitro against rhMIS

286 Ovarian carcinoma cell lines were transfected in vitro with dl92

287 Ovarian carcinoma cell lines were used to evaluate the effects o

288 and from low-grade to high-grade urothelial carcinoma cell lines, whereas alternatively spliced vari

289 L14 secretion by head and neck squamous cell carcinoma cell lines, whereas reintroduction of RhoBTB2

290 nt was enriched to MAF = 0.64 in NCI-60 lung carcinoma cell lines, whereas the TOP1MT R525W was enric

291 In the 4TO7 mouse carcinoma cell line, which expresses low levels of endog

292 Treatment of a human colon carcinoma cell line with alpha-DABA versus gamma-DABA ha

293 Incubation of a human embryonal carcinoma cell line with NMM reduces its stem cell trait

294 that it is applicable to 10 human colorectal carcinoma cell lines with a direct correlation between v

295 cificity of tumor cell targeting using three carcinoma cell lines with different levels of EGFR expre

296 ed miRNA characterized from isogenic bladder carcinoma cell lines with differing metastatic potential

297 tment of both APC mutant zebrafish and human carcinoma cell lines with retinoic acid significantly re

298 on of four human head and neck squamous cell carcinoma cell lines with the complete ppFur cDNA sequen

299 ementation of VHL-defective clear cell renal carcinoma cell lines with wild-type VHL restored primary

300 A2780cis (cisplatin-resistant human ovarian carcinoma) cell lines, with selected complexes' being mo